Case Series Investigating the Clinical Practice Experience of Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) in the Clinical Management of Patients with Inflammatory Bowel Disease
@article{Good2015CaseSI, title={Case Series Investigating the Clinical Practice Experience of Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) in the Clinical Management of Patients with Inflammatory Bowel Disease}, author={Larry I Good and Raymond Michael Panas}, journal={Journal of Gastrointestinal and Digestive System}, year={2015}, volume={2015} }
Background: Serum-derived bovine immunoglobulin/protein isolate (SBI), a specially formulated oral protein source of >50% IgG and ~60% total immunoglobulins, has a multifaceted mechanism of action binding microbial components, maintaining gastrointestinal immune balance, managing gut barrier function and improving nutrient utilization. IBD animal models and a human refractory case study demonstrated that SBI can attenuate both inflammatory biomarkers and histological parameters in the bowel…
Figures from this paper
10 Citations
Clinical Efficacy of Serum‐Derived Bovine Immunoglobulin in Patients With Refractory Inflammatory Bowel Disease
- MedicineThe American journal of the medical sciences
- 2018
Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin
- MedicineTherapeutic advances in gastroenterology
- 2015
It is suggested that SBI improves clinical management of IBD patients who are not fully managed on traditional therapies and should be considered for the nutritional support of I BD regardless of disease activity, location, phenotype, duration, or complexity.
Clinical and Pathologic Remission of Pediatric Ulcerative Colitis with Serum-Derived Bovine Immunoglobulin Added to the Standard Treatment Regimen
- MedicineCase Reports in Gastroenterology
- 2017
A detailed case of pediatric UC is presented, including documentation of mucosal healing and decrease in pediatric UC activity index in a difficult to treat pediatric patient, after the addition of SBI to this patient’s treatment regimen.
Is There a Role for the Enteral Administration of Serum-Derived Immunoglobulins in Human Gastrointestinal Disease and Pediatric Critical Care Nutrition?
- MedicineAdvances in nutrition
- 2016
Oral Ig may emerge as an important "add-on" therapy for a variety of gastrointestinal and nutritional problems during the next decade, by aiding in disease control without immunosuppressive side effects.
The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.
- MedicineGastroenterology & hepatology
- 2017
The history and development of medical foods under the FDA is discussed and specifically on medical foods used to help manage diseases of the gastrointestinal tract are focused on.
Long-term Management of Pouchitis-Associated Diarrhea with Serum-Derived Bovine Immunoglobulin/Protein Isolate
- MedicineClinical & Experimental Gastroenterology & Hepatology
- 2019
It was not until the addition of serum-derived bovine immunoglobulin/protein isolate (SBI) that 8 of 10 patients experienced satisfactory management of their pouchitis-associated diarrhea and these patients demonstrate beneficial effects in the long-term management of diarrhea-associated with pouchitis.
A Short Review on Gastrointestinal Disorders
- Medicine
- 2016
ABSTRACT
Knowledge about the psychosocial aspects of the gastrointestinal disorders is fundamental and critical to the understanding of the gastrointestinal disorders and their effective treatment.…
A Review on Recent Publications Using Microwaves in Synthesis of Biologically Active Molecules
- Chemistry
- 2015
Applications of all microwaves in the synthesis of chemical moieties which are biologically active have been discussed with a short briefing of advantages of these techniques over the conventional approaches.
Case Series Investigating the Clinical Practice Experience of Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) in the Clinical Management of Patients with Inflammatory Bowel Disease
- Medicine
- 2015
Serum-derived bovine immunoglobulin/protein isolate, a specially formulated oral protein source, has a multifaceted mechanism of action binding microbial components, maintaining gastrointestinal immune balance, managing gut barrier function and improving nutrient utilization.
References
SHOWING 1-10 OF 21 REFERENCES
A Case of Short Bowel Syndrome Managed With a Prescription Medical Food Product, Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI): 1521
- Medicine
- 2014
A medical food consisting of serum-derived bovine immunoglobulin/protein isolate (SBI) was utilized in a 37-year-old Caucasian female to manage SBS and may help improve nutritional status in SBS as well as manage chronic diarrhea and global symptoms of abdominal pain, bloating, and distention.
Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy
- MedicineClinical and experimental gastroenterology
- 2014
Preliminary evidence is provided that a serum-derived bovine immunoglobulin/protein isolate is safe and improves symptoms, nutritional status, and various biomarkers associated with enteropathy in patients with HIV infection or diarrhea-predominant irritable bowel syndrome.
Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects with Diarrhea-Predominant Irritable Bowel Syndrome
- MedicineClinical medicine insights. Gastroenterology
- 2013
This pilot study showed that nutritional therapy with either 10 g/day or 5 g/ day of SBI in 30 patients was well tolerated and resulted in statistically significant within group improvements in both symptom days and in daily symptom scores in subjects with IBS-D.
Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy
- MedicineAIDS
- 2013
SBI significantly increases intestinal mucosal CD4+ lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.
New pathophysiological insights and modern treatment of IBD
- Medicine, BiologyJournal of Gastroenterology
- 2010
This review summarizes current epidemiology, pathogenesis and diagnostic strategies in IBD, provides insight in today’s differentiated clinical therapy and describes mechanisms of promising future medicinal approaches.
Converging goals of treatment of inflammatory bowel disease from clinical trials and practice.
- MedicineGastroenterology
- 2015
A combination of end points, comprising patient-reported outcomes and objective evaluation of inflammation by endoscopy, offers a clinically meaningful and scientifically valid alternative to existing composite indices.
Management of Loose, Frequent Stools and Fecal Incontinence in a Chronic Mesenteric Ischemia Patient with Oral Serum-derived Bovine Immunoglobulin
- MedicineClinical medicine insights. Gastroenterology
- 2015
This case underscores how a safe, nutritional therapy may offer a new modality for physicians to address chronic loose, frequent stools with FI in patients with CMI in this difficult to manage gastrointestinal population.
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis.
- Medicine, BiologyGastroenterology
- 2011
The transcriptional profile of the mucosa appears to interact with the colonic microbiota; this interaction appears to be lost in colon of patients with UC, which has different gene expression profiles and lower levels of biodiversity than their healthy twins.
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease
- MedicineGut
- 2007
Upregulation of pore-forming claudin 2 and downregulation and redistribution of sealing claudins 5 and 8 lead to altered tight junction structure and pronounced barrier dysfunction already in mild to moderately active Crohn’s disease.